The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Program Evaluation

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Program Evaluation

 

High impact information on Program Evaluation

 

Biological context of Program Evaluation

  • To gather more insight into the mechanisms that underlie these drug interactions and to develop guidelines for further improvement of clinical combination protocols, we performed a broad preclinical evaluation program of ifosfamide-based combination regimens using isobologram analysis of drug interactions [9].
  • As part of the international evaluation program coordinated by ILSI/HESI, the potential of DNA repair deficient Xpa-/- mice and the double knockout Xpa-/-.p53+/- mice for short term carcinogenicity assays was evaluated [10].
  • A comprehensive evaluation program was used for the within-subject comparisons, including assessment of potential dermal exposure, actual dermal exposure, inhalation exposure, and internal dose as measured by the urinary metabolite 3,5,6-trichloro-2-pyridinol (TCP) [11].
 

Associations of Program Evaluation with chemical compounds

  • Seven manufacturers voluntarily submitted their products for evaluation in the Center for Disease Control Premarket Evaluation Program. Each product was tested in accordance with the Center for Disease Control performance and labeling specifications and evaluation methods [12].
  • Sugar has been fortified with vitamin A in Central American countries for years, and biological efficacy and program effectiveness are well established [13].
  • Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations [14].
  • (Stedman, D. H.; Bishop, G. A.; Aldrete, P.; Slott, R. S. Environ. Sci. Technol. 1997, 31, 927-931) introduced the Step Method of evaluation when they presented the results of a 1995 Denver I/M program evaluation [15].
  • The Faculty of Medicine at Sherbrooke (in Quebec, Canada), following a major curricular reform begun in the mid-1980s, held three external, formative program evaluations in 1988, 1991, and 1994, using expert judgment and "connoisseur" models of evaluation [16].
 

Gene context of Program Evaluation

  • The Commission on Accreditation of Rehabilitation Facilities (CARF) has for more than two decades required accredited organizations to have active outcome-oriented program evaluation systems [17].
  • Inspection/maintenance program evaluation: replicating the Denver Step Method for an Atlanta fleet [15].
  • Re: Automated Fabrication of Mobility Aids (AFMA): below-knee CASD/CAM testing and evaluation program results [18].
  • A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey [19].
  • Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute [20].
 

Analytical, diagnostic and therapeutic context of Program Evaluation

  • DESIGN: From August 1994 to January 1996, enzyme immunoassay testing accuracy was assessed for laboratories participating in the Centers for Disease Control and Prevention Model Performance Evaluation Program that provided information regarding their use of QC material [21].
  • PURPOSE: We propose national standards previously recommended for the Long-Term Care Ombudsman Program by an Institute of Medicine program evaluation committee, and introduce a tool to measure the compliance of local ombudsman programs to those standards: the Huber Badrak Borders Scales [22].
  • The Centers for Disease Control and Prevention convened a panel of experts knowledgeable about community-based program evaluation and cardiovascular disease (CVD) prevention to develop a list of CLIs, and rate their feasibility, reliability and validity [23].

References

  1. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: The Kidney Early Evaluation Program. El-Achkar, T.M., Ohmit, S.E., McCullough, P.A., Crook, E.D., Brown, W.W., Grimm, R., Bakris, G.L., Keane, W.F., Flack, J.M. Kidney Int. (2005) [Pubmed]
  2. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Peterson, E.A., Milliron, K.J., Lewis, K.E., Goold, S.D., Merajver, S.D. Cancer Epidemiol. Biomarkers Prev. (2002) [Pubmed]
  3. Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs. Hooks, W.N., Burford, P., Begg, S., Gopinath, C., Inage, F., Kato, M., Takayama, S. Arzneimittel-Forschung. (1994) [Pubmed]
  4. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Brose, M.S., Rebbeck, T.R., Calzone, K.A., Stopfer, J.E., Nathanson, K.L., Weber, B.L. J. Natl. Cancer Inst. (2002) [Pubmed]
  5. Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program. Farinaro, E., Stamler, J., Upton, M., Mojonnier, L., Hall, Y., Moss, D., Berkson, D.M. Ann. Intern. Med. (1977) [Pubmed]
  6. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. Chute, J.P., Chen, T., Feigal, E., Simon, R., Johnson, B.E. J. Clin. Oncol. (1999) [Pubmed]
  7. An artificial intelligence approach to the study of the structural moieties relevant to drug-receptor interactions in aldose reductase inhibitors. Klopman, G., Buyukbingol, E. Mol. Pharmacol. (1988) [Pubmed]
  8. A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer. Goel, S., Wadler, S., Hoffman, A., Volterra, F., Baker, C., Nazario, E., Ivy, P., Silverman, A., Mani, S. Investigational new drugs. (2003) [Pubmed]
  9. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic. Vanhoefer, U., Schleucher, N., Klaassen, U., Seeber, S., Harstrick, A. Semin. Oncol. (2000) [Pubmed]
  10. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with haloperidol, reserpine, phenacetin, and D-mannitol. Lina, B.A., Woutersen, R.A., Bruijntjes, J.P., van Benthem, J., van den Berg, J.A., Monbaliu, J., Thoolen, B.J., Beems, R.B., van Kreijl, C.F. Toxicologic pathology. (2004) [Pubmed]
  11. Effectiveness of personal protective equipment: relevance of dermal and inhalation exposure to chlorpyrifos among pest control operators. van der Jagt, K., Tielemans, E., Links, I., Brouwer, D., van Hemmen, J. Journal of occupational and environmental hygiene. (2004) [Pubmed]
  12. Premarket evaluation of commercial toxoplasmosis indirect fluorescent-antibody reagents. Durham, T.M., Colvin, H.M. J. Clin. Microbiol. (1978) [Pubmed]
  13. Food fortification to reduce vitamin A deficiency: International Vitamin A Consultative Group recommendations. Dary, O., Mora, J.O. J. Nutr. (2002) [Pubmed]
  14. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Davidson, M.H., Maki, K.C., Pearson, T.A., Pasternak, R.C., Deedwania, P.C., McKenney, J.M., Fonarow, G.C., Maron, D.J., Ansell, B.J., Clark, L.T., Ballantyne, C.M. Am. J. Cardiol. (2005) [Pubmed]
  15. Inspection/maintenance program evaluation: replicating the Denver Step Method for an Atlanta fleet. Corley, E.A., Dehart-Davis, L., Lindner, J., Rodgers, M.O. Environ. Sci. Technol. (2003) [Pubmed]
  16. Sustaining curricular change at Sherbrooke through external, formative program evaluations. Des Marchais, J.E., Bordage, G. Academic medicine : journal of the Association of American Medical Colleges. (1998) [Pubmed]
  17. Accreditation and the use of outcomes-oriented information systems. Wilkerson, D.L. Archives of physical medicine and rehabilitation. (1997) [Pubmed]
  18. Re: Automated Fabrication of Mobility Aids (AFMA): below-knee CASD/CAM testing and evaluation program results. Goldstone, J., Kramer, D., Doyle, W., Daley, P. Journal of rehabilitation research and development. (1993) [Pubmed]
  19. A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey. Maki, K.C., Davidson, M.H., Dicklin, M.R. The Canadian journal of cardiology. (2006) [Pubmed]
  20. Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment. International Life Sciences Institute. Robinson, D.E., MacDonald, J.S. Toxicologic pathology. (2001) [Pubmed]
  21. Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies. Astles, J.R., Lipman, H.B., Schalla, W.O., Blumer, S.O., Fehd, R.J., Smith, C., Hearn, T.L. Arch. Pathol. Lab. Med. (1998) [Pubmed]
  22. National standards for the long-term care ombudsman program and a tool to assess compliance: the Huber Badrak Borders Scales. Huber, R., Borders, K.W., Badrak, K., Netting, F.E., Nelson, H.W. The Gerontologist. (2001) [Pubmed]
  23. Promising community-level indicators for evaluating cardiovascular health-promotion programs. Cheadle, A., Sterling, T.D., Schmid, T.L., Fawcett, S.B. Health education research. (2000) [Pubmed]
 
WikiGenes - Universities